EL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Estee Lauder is not a strong buy right now for a Beginner with a long-term focus and $50,000-$100,000 to deploy. The stock shows real turnaround progress and improving analyst targets, but the setup is mixed: price is near short-term resistance, insiders and congress trading lean negative, and there is no Intellectia buy signal. For an impatient investor, this is a hold rather than a buy today.
EL closed at 84.80 after a -1.59% regular-session decline, slightly below the previous close of 85.29 and just under the R1 resistance at 85.886. The MACD histogram is positive and expanding, which supports an improving trend, but the short-term RSI_6 at 75.821 suggests the move is extended rather than offering a clean entry. Moving averages are converging, indicating a developing trend but not yet a decisive breakout. Support sits at 81.043 pivot and 76.199 S1. Overall, momentum is constructive but the current price is not an attractive low-risk entry.
["Q3 revenue rose 4.56% YoY to 3.712B, showing top-line recovery.", "Gross margin improved to 76.4%, up 1.92% YoY, suggesting better efficiency.", "Analysts broadly lifted price targets after Q3, with several firms maintaining or upgrading constructive views.", "News reported Q1 revenue beat expectations and raised full-year adjusted EPS guidance to $2.40.", "Projected sales growth of 3%-5% for fiscal 2027 supports a longer-term turnaround thesis."]
["A $210M settlement tied to shareholder fraud allegations creates an overhang.", "Net income fell 44.03% YoY and EPS dropped 45.45% YoY in the latest quarter, so profitability is still weak.", "Insiders are selling, and the amount sold increased sharply over the last month.", "Congress trading shows 1 sale and 0 purchases, which is a cautious signal.", "Several analysts remain Neutral/Hold/Equal Weight, showing the Street is improving but still split.", "The stock is near resistance, limiting immediate upside from the current price."]
Latest quarter shown is 2026/Q3. Revenue increased to 3.712B, up 4.56% YoY, which is a positive growth trend. Gross margin improved to 76.4% and was up 1.92% YoY, showing stronger operating quality. However, net income fell to 89M, down 44.03% YoY, and EPS fell to 0.24, down 45.45% YoY. So the company is growing sales and improving margins, but earnings remain under pressure.
Analyst sentiment has improved, with multiple firms raising price targets after Q3 results. Bullish voices include Deutsche Bank (Buy, PT 108) and JPMorgan (Overweight, PT 99), while several others remain Neutral/Equal Weight/Hold, including Barclays, UBS, Morgan Stanley, Wells Fargo, Canaccord, and B. Riley. The overall Wall Street view is constructive but not fully confident: pros point to organic sales improvement, cost discipline, and margin progress; cons center on needing more visibility, recovery in China and travel retail, and lingering uncertainty from litigation and acquisition speculation.
